相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula Gonzalez-Ericsson et al.
JOURNAL OF PATHOLOGY (2020)
Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
Silvia Gonzalez-Martinez et al.
CANCERS (2020)
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
Emarene Kalaw et al.
BRITISH JOURNAL OF CANCER (2020)
Immune parameters associated with survival in metaplastic breast cancer
Xue Chao et al.
BREAST CANCER RESEARCH (2020)
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
S. Loibl et al.
ANNALS OF ONCOLOGY (2019)
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
Nancy Tray et al.
BREAST (2019)
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival
Michelle Afkhami et al.
PLOS ONE (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
Nobumoto Tomioka et al.
BREAST CANCER (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma
Gregor Krings et al.
MODERN PATHOLOGY (2018)
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
Upasana Joneja et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
Hitomi Mori et al.
ONCOTARGET (2017)
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation
Fumi Kawakami et al.
CANCER (2017)
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Dramatic response of metaplastic breast cancer to chemo-immunotherapy
Sylvia Adams
NPJ BREAST CANCER (2017)
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages An Assessment of 245 Primary and 40 Metastatic Tumors
Erik A. Dill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
Sehui Kim et al.
EUROPEAN JOURNAL OF CANCER (2015)
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment
Adnan Aydiner et al.
MEDICINE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
I. C. Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base
Christopher M. Pezzi et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
分享论文
